Cargando…

Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study

Objective: To analyze the clinical outcomes of patients with type 2 diabetes (T2D) before and after implementation of a personalized care plan in the primary health care setting. Design: Observational, retrospective, real-world study. Setting: All T2D patients with a care plan in Rovaniemi Health Ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Vuohijoki, Anni, Mikkola, Ilona, Jokelainen, Jari, Keinänen-Kiukaanniemi, Sirkka, Winell, Klas, Frittitta, Lucia, Timonen, Markku, Hagnäs, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252372/
https://www.ncbi.nlm.nih.gov/pubmed/32450742
http://dx.doi.org/10.1177/2150132720921700
_version_ 1783539147943706624
author Vuohijoki, Anni
Mikkola, Ilona
Jokelainen, Jari
Keinänen-Kiukaanniemi, Sirkka
Winell, Klas
Frittitta, Lucia
Timonen, Markku
Hagnäs, Maria
author_facet Vuohijoki, Anni
Mikkola, Ilona
Jokelainen, Jari
Keinänen-Kiukaanniemi, Sirkka
Winell, Klas
Frittitta, Lucia
Timonen, Markku
Hagnäs, Maria
author_sort Vuohijoki, Anni
collection PubMed
description Objective: To analyze the clinical outcomes of patients with type 2 diabetes (T2D) before and after implementation of a personalized care plan in the primary health care setting. Design: Observational, retrospective, real-world study. Setting: All T2D patients with a care plan in Rovaniemi Health Center, Rovaniemi, Finland, for whom data were available from a baseline visit (in 2013-2015 during which the care plan was written) and from a follow-up visit, including an updated care plan by the year 2017. Subjects: In total, 447 patients were included. Mean age was 66.9 (SD 10.1) years, 58.8% were male, 15.4% were smokers, 33.1% had vascular disease, and 17.0% were receiving insulin treatment. The mean follow-up time was 14.4 months. Main Outcome Measures: Glycosylated hemoglobin A1 (HbA1c), low-density lipoprotein (LDL), blood pressure (BP), and body mass index (BMI). Clinical values were taken at both baseline and follow-up. Results: LDL decreased by 0.2 mmol/L, systolic blood pressure by 2.2 mm Hg, diastolic blood pressure by 1.5 mm Hg, and BMI by 0.5 kg/m(2) (P < .05 for each). The decrease in HbA1c was 0.8 mmol/mol (P = .07). Conclusion: We observed statistically significant decreases in LDL, BP, and BMI. Our results indicate that, over 14 months of follow-up, implementation of a written care plan was associated with small improvements in the clinical outcomes of T2D patients in a primary health care study population in a real-world setting.
format Online
Article
Text
id pubmed-7252372
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-72523722020-06-08 Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study Vuohijoki, Anni Mikkola, Ilona Jokelainen, Jari Keinänen-Kiukaanniemi, Sirkka Winell, Klas Frittitta, Lucia Timonen, Markku Hagnäs, Maria J Prim Care Community Health Original Research Objective: To analyze the clinical outcomes of patients with type 2 diabetes (T2D) before and after implementation of a personalized care plan in the primary health care setting. Design: Observational, retrospective, real-world study. Setting: All T2D patients with a care plan in Rovaniemi Health Center, Rovaniemi, Finland, for whom data were available from a baseline visit (in 2013-2015 during which the care plan was written) and from a follow-up visit, including an updated care plan by the year 2017. Subjects: In total, 447 patients were included. Mean age was 66.9 (SD 10.1) years, 58.8% were male, 15.4% were smokers, 33.1% had vascular disease, and 17.0% were receiving insulin treatment. The mean follow-up time was 14.4 months. Main Outcome Measures: Glycosylated hemoglobin A1 (HbA1c), low-density lipoprotein (LDL), blood pressure (BP), and body mass index (BMI). Clinical values were taken at both baseline and follow-up. Results: LDL decreased by 0.2 mmol/L, systolic blood pressure by 2.2 mm Hg, diastolic blood pressure by 1.5 mm Hg, and BMI by 0.5 kg/m(2) (P < .05 for each). The decrease in HbA1c was 0.8 mmol/mol (P = .07). Conclusion: We observed statistically significant decreases in LDL, BP, and BMI. Our results indicate that, over 14 months of follow-up, implementation of a written care plan was associated with small improvements in the clinical outcomes of T2D patients in a primary health care study population in a real-world setting. SAGE Publications 2020-05-26 /pmc/articles/PMC7252372/ /pubmed/32450742 http://dx.doi.org/10.1177/2150132720921700 Text en © The Author(s) 2020 https://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Vuohijoki, Anni
Mikkola, Ilona
Jokelainen, Jari
Keinänen-Kiukaanniemi, Sirkka
Winell, Klas
Frittitta, Lucia
Timonen, Markku
Hagnäs, Maria
Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title_full Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title_fullStr Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title_full_unstemmed Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title_short Implementation of a Personalized Care Plan for Patients With Type 2 Diabetes Is Associated With Improvements in Clinical Outcomes: An Observational Real-World Study
title_sort implementation of a personalized care plan for patients with type 2 diabetes is associated with improvements in clinical outcomes: an observational real-world study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252372/
https://www.ncbi.nlm.nih.gov/pubmed/32450742
http://dx.doi.org/10.1177/2150132720921700
work_keys_str_mv AT vuohijokianni implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT mikkolailona implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT jokelainenjari implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT keinanenkiukaanniemisirkka implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT winellklas implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT frittittalucia implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT timonenmarkku implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy
AT hagnasmaria implementationofapersonalizedcareplanforpatientswithtype2diabetesisassociatedwithimprovementsinclinicaloutcomesanobservationalrealworldstudy